key: cord-0860264-i66diwwz
authors: Thomas, Cristina
title: Reply to: “A Dermatologic Manifestation of COVID-19: Transient Livedo Reticularis”
date: 2020-05-07
journal: J Am Acad Dermatol
DOI: 10.1016/j.jaad.2020.04.164
sha: 5b4631cc407f64a63e97b8c423a005db96574307
doc_id: 860264
cord_uid: i66diwwz

nan

With any emerging disease, we must integrate a rapidly evolving evidence base into our 

A dermatologic manifestation of COVID-19: 78 transient livedo reticularis

Abnormal coagulation parameters are associated with poor 81 prognosis in patients with novel coronavirus pneumonia

Anticoagulant treatment is associated with decreased 84 mortality in severe coronavirus disease 2019 patients with coagulopathy

Clinical features of patients infected with 2019 novel 87 coronavirus in Wuhan

SARS-CoV-2 cell entry depends on 90 ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor